Discontinuation report ZOFRAN ODT
Report ID | 177540 |
Drug Identification Number | 02239373 |
Brand name | ZOFRAN ODT |
Common or Proper name | ZOFRAN ODT TABS 8MG (1X10) |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 8MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 8MG (1X10) |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2023-02-01 |
Actual discontinuation date | 2023-02-06 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-12-08 | English | Compare |
v2 | 2022-12-08 | English | Compare |
v3 | 2022-12-08 | French | Compare |
v4 | 2023-03-14 | English | Compare |
v5 | 2023-03-14 | French | Compare |
Showing 1 to 5 of 5